Found 24 matching trials
A Pilot Study Of the Effects of Highly Active Antiretroviral Therapy on Kaposi's Sarcoma in Zimbabwe PHASE2 Open-label study of a regimen of antiretrovirals for the treatment of AIDS-...
Show More Location
University of Zimbabwe College of Health Sciences Department of Medicine
Learn More & Join Trial
Study to Evaluate the Effectiveness of ABC+3TC +EFV in Once-Daily Regimens Versus KLT in Twice-Daily Regimens in Naive HIV Patients PHASE3 To evaluate the therapeutic equivalence between the two arms of treatment i...
Show More Location
Institute of Infections and Tropical Diseases University of Brescia
Learn More & Join Trial
Efavirenz to Dolutegravir Switch in Patients With CNS Toxicity PHASE4 This is a phase IV, open label, multicentre trial that will be taking place...
Show More Location
Chelsea and Westminster Hospital
Learn More & Join Trial
Relative Bioavailability Study of Two New Dolutegravir/Abacavir/Lamivudine Fixed Dose Combination Tablets PHASE1 Dolutegravir (DTG, GSK1349572) is a next-generation integrase inhibitor (IN...
Show More Location
GSK Investigational Site
Learn More & Join Trial
Renal Effect of Stribild or Other Tenofovir DF-containing Regimens Compared to Ritonavir-boosted Atazanavir Plus Abacavir/Lamivudine in Antiretroviral Treatment-naive HIV-1 Infected Adults PHASE4 The primary objective of this study is to assess glomerular function before...
Show More Location
Multiple Locations
Learn More & Join Trial
A Prospective, Open-label Trial of Two ABC/3TC Based Regimens in Late Presenter naïve Patients (CD4 <200 Cells/µL) PHASE3 1\. PROTOCOL SUMMARY This is a prospective, randomized open-label, 2 arm, 3...
Show More Location
University of Modena and Reggio Emilia
Learn More & Join Trial
Dual Therapy With Boosted Darunavir + Dolutegravir PHASE3 A switch strategy to investigate whether a dual therapy with Ritonavir-boos...
Show More Location
Klinikum rechts der Isar
Learn More & Join Trial
ROCKET II - Randomized Open Label Switch for Cholesterol Elevation on Kivexa + Kaletra Evaluation Trial PHASE4 This study investigated whether human immunodeficiency virus type 1 (HIV-1)...
Show More Learn More & Join Trial
Safety and Efficacy of Doravirine (MK-1439) in Participants With Human Immunodeficiency Virus 1 (HIV-1) (MK-1439-018) PHASE3 To establish a new treatment option for treatment-naïve participants with H...
Show More Location
Multiple Locations
Learn More & Join Trial
Changes in Cerebral Function in Treatment Naive HIV-1 Infected Subjects Commencing Either Boosted Atazanavir With Truvada or Boosted Darunavir With Maraviroc and Kivexa PHASE4 The purpose of this study is to compare two different combination anti-HIV ...
Show More Location
Birmingham Heartlands Hospital:
Learn More & Join Trial